Clinical Trial Update: CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical protocol update assessing long-term safety and efficacy of metreleptin in various forms of partial lipodystrophy; study status completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Partial Lipodystrophy
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Metreleptin (metreleptin)

Snippet

Sponsor: University of Michigan | Conditions: Familial Partial Lipodystrophy, Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-11-24